FOLLOW HEART TRANSPLANT FOR ACHIEVING THE HEART PRIMITIVE RELATED SCLERODERMA SYSTEMIC

University Hospital, Strasbourg, France9 enrolled

Overview

Systemic sclerosis is a rare disease. The early cardiac disease affects 10% of patients sclérodemiques. Heart transplantation in the early cardiac involvement in systemic sclerosis is exceptional. we see patient data analysis with systemic sclerosis who used cardiac transplantation to understand the primitive cardiac damage associated with systemic sclerosis

Study Type

OBSERVATIONAL

Enrollment

Conditions

Systemic Sclerosis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * Adult patients meet the criteria for classification of systemic sclerosis * Adverse primitive heart that required a heart transplant * Patients who have given their verbal agreement to use their data for research purposes. Exclusion criteria: * Localized Scleroderma or sclerodermiform syndrome * Heart disease secondary to pulmonary or renal impairment * Refusal to participate in the study

Outcomes

Primary Outcomes

Analysis of data from patients with systemic sclerosis who used cardiac transplantation for primary cardiac involvement

Time frame: 1month post-transplantation

Central Contacts

Emmanuel CHATELUS, MD

CONTACT

33 (0)3.88.12.81.15 emmanuel.chatelus@chru-strasbourg.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.